The Converse Pharma Group is pleased to announce that in line with our ongoing investment strategy, the expansion of our Crompton Road Facility in Doncaster to create a new central distribution hub for the group. The facility will undertake all distribution activity on behalf of Doncaster Pharmaceuticals, and provide a central distribution hub for […]
In October 2013 Mark Gulliford and Andy Wilson completed the £37m management buyout of three trading entities from previous parent company Mawdsleys. The DE Group, Doncaster Pharmaceuticals Group, and Eurodrug were purchased through an asset based lending package provided by RBS invoice financing.
The £37m deal consists of an Asset Based Lending (ABL) line provided […]